Ideaya Biosciences (IDYA) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Clean Conservation Emission Environment Environmental Intensity Materials Nature Offset Package Packaging Pandemic Pollution Raw Materials Scarce Toxic Waste Water Access African American Asian Benefits Black California Consumer Privacy Act Collective Bargaining Community Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Demographic Disability Diversity Drug Pricing Employee Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Injuries Injury LGBTQ Minority Perquisites Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Supplier Supply Chain Talent Training Union Volunteer Workers Workforce Action Plan Antitrust Assessment Assurance Audit Bonus Bribe Chronic Classified Classified Board Commitment Corporate Governance Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Mission Oversee Oversight Perquisite Purpose R&D Reputation Reputational Research and Development Responsibility Responsible Special Meeting Strategy Sustainable Targets Tax Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 9, 2022, IDEAYA Biosciences, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 26, 2022. Only stockholders of record as of the close of business on April 12, 2022, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 38,632,622 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. The tabulation of the stockholder votes on each proposal brought before the Annual Meeting is as follows:

Proposal 1. The election of three Class III directors to hold office until the 2025 annual meeting of stockholders or until their respective successors are elected:

Nominee

Susan L. Kelley, M.D.	30,165,016	3,442,946	2,961,916
Scott W. Morrison	20,373,793	13,234,169	2,961,916
Jeffrey L. Stein, Ph.D.	18,072,384	15,535,578	2,961,916

Proposal 2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2022:


Votes For		Votes Against		Abstentions
	36,533,072		36,756		50

As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.